Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: March 06, 2026
Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.
Journal: British journal of haematology
Published: February 04, 2026
Discovery of a novel ITPR2::KRAS fusion in large cell neuroendocrine lung cancer: a case report.
Journal: Translational lung cancer research
Published: November 21, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.
Journal: Nature medicine
Published: September 04, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
GPR81 nuclear transportation is critical for cancer growth and progression in lung and other solid cancers.
Journal: World journal of clinical oncology
Published: March 18, 2025
SFPQ subcellular mislocalisation entails altered cancer cell function.
Journal: Clinical and translational medicine
Published: March 13, 2025
Cancer-Associated Retinopathy as the Sole Presenting Sign of Small Cell Lung Cancer: A Case Report.
Journal: Cureus
Published: January 01, 2025
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers.
Journal: International journal of molecular sciences
Published: July 02, 2024
Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 26, 2023
SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: July 12, 2023
Last Updated: 09/26/2026